6.19MMarket Cap
LossP/E TTM
X T L Biopharmaceuticals Ltd
XTLB Financials
See X T L Biopharmaceuticals Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
X T L Biopharmaceuticals Ltd Earnings Date
Latest Release
Jun 30, 2026
FAQs
What are the current assets of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its current assets were 166.00K, with a year-on-year change of -87.61.
What are the total assets of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its total assets of X T L Biopharmaceuticals Ltd were 166.00K, with a year-on-year change of -98.06.
What are the total liabilities of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its total liabilities of X T L Biopharmaceuticals Ltd were 420.00K, with a year-on-year change of -86.52.
What is the total equity of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its total equity of X T L Biopharmaceuticals Ltd was -254.00K, with a year-on-year change of -104.67.
What is the net operating income of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its net operating income of X T L Biopharmaceuticals Ltd was -1.47M, with a year-on-year change of 32.55.
What is the net investment of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its net investment of X T L Biopharmaceuticals Ltd was 522.00K, with a year-on-year change of 159.45.
What is the net financing of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its net financing of X T L Biopharmaceuticals Ltd was 208.00K, with a year-on-year change of -85.63.
What is the Earnings Per Share (EPS) of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -0.78, with a year-on-year change of -408.50.
What is the net income of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its net income was -6.97M, with a year-on-year change of -578.58.
What is the debt-to-asset ratio of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its debt-to-asset ratio was 162.05, with a year-on-year change of 9939.91.
What is the Return on Equity (ROE) of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its Return on Equity (ROE) was -29.30, with a year-on-year change of -9.20.
What is the Return on Assets (ROA) of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its Return on Assets (ROA) was -17.42, with a year-on-year change of 6.93.
What is the operating profit of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its operating profit was -1.47M, with a year-on-year change of 32.55.